Clinical Trial

Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-centre, single-arm, observational trial to assess the safety and efficacy of corifollitropin alfa N02 Injection in elderly Chinese women undergoing ART, and then to explore the compliance and satisfaction during COS treatment.
Trial Details
NCT Number NCT07553728
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Infertility
Enrollment 200 participants
Start Date 2026-05-01
Primary Completion 2029-08-04 (estimated)
Study Completion 2029-12-16 (estimated)
Updated on ClinicalTrials.gov 2026-04-28